Results 1 to 10 of about 1,610,621 (331)

Predictors of unplanned 30-day hospital readmission: a retrospective cohort study in north-east Italy [PDF]

open access: yesBMJ Open
Objective Unplanned hospital readmissions within 30 days of discharge measure the quality of healthcare. This study aims to identify the characteristics of patients at higher risk of readmission.Design Retrospective cohort study.Setting North-east Italy (
Alessandra Buja   +11 more
doaj   +2 more sources

Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study [PDF]

open access: yesAntibodies
Background: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear.
Matteo Bonato   +5 more
doaj   +2 more sources

Determinants of Clinical Remission in Dupilumab-Treated Severe Eosinophilic Asthma: A Real-World Retrospective Study [PDF]

open access: yesBiomedicines
Background: Dupilumab, a monoclonal antibody targeting the IL-4/IL-13 receptor, has shown significant efficacy in improving asthma control and reducing exacerbations in patients with severe eosinophilic asthma. However, there is a lack of knowledge about
Matteo Bonato   +7 more
doaj   +2 more sources

Dexmedetomidine for LISA procedure: a prospective observational single center experience [PDF]

open access: yesItalian Journal of Pediatrics
Background Respiratory Distress Syndrome (RDS) is the most common respiratory problem of preterm newborns. The preferred way to manage RDS is with Less Invasive Surfactant Administration (LISA), which involves direct laryngoscopy in spontaneously ...
Beatrice Galeazzo   +6 more
doaj   +2 more sources

Risk factors for 30-day unplanned readmissions after surgical procedures in the elderly population [PDF]

open access: yesPatient Safety in Surgery
Introduction Urgent hospital readmissions within 30 days of discharge after surgery are a measure of the quality of health and social care. This study aims to identify the characteristics of patients at higher risk of readmission and the main reasons for
Gino Sartor   +6 more
doaj   +2 more sources

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge

open access: yesFrontiers in Immunology, 2021
B cell-targeting strategies such as rituximab are widely used in B cell hematologic malignancies, rheumatologic and musculoskeletal diseases and a variety of autoimmune disorders.
Anna Furlan   +6 more
doaj   +1 more source

Novel three-dimensional acellular dermal matrix for prepectoral breast reconstruction: First year in review with BRAXON®Fast

open access: yesFrontiers in Surgery, 2022
Implant-based breast reconstruction is part of breast cancer treatment, and increasingly optimized reconstructive procedures exploit highly biocompatible materials to ensure enhanced aesthetic-functional results.
Giorgio Berna   +8 more
doaj   +1 more source

Novel Polyethylene Terephthalate Screw Sleeve Implant: Salvage Treatment in a Case of Spine Instability after Vertebroplasty Failure

open access: yesMedicines, 2022
Introduction: The management of osteoporotic fractures is sometimes rather challenging for spinal surgeons, and considering the longer life expectancy induced by improved living conditions, their prevalence is expected to increase.
Giacomo Drago   +6 more
doaj   +1 more source

Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution

open access: yesHematology Reports, 2022
The present paper reports, to the best of our knowledge for the first time, the efficacy and tolerability of the combination of interferon (IFN)α-2a in pegylated formulation and rituximab after a “priming” phase with IFN in the frontline treatment of ...
Anna Furlan   +3 more
doaj   +1 more source

Bleeding Risk in Patients with Peripheral Arterial Disease

open access: yesLife, 2022
Patients with peripheral arterial disease (PAD) are at high risk of major adverse cardiac events (MACE) and major adverse limb events (MALE). Recently, antithrombotic therapies employing antiplatelet and anticoagulant drugs have proven to be valid in ...
Adriana Visonà   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy